FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study

BACKGROUND: FOLFIRINOX and gemcitabine plus nab-paclitaxel (Gem + nabPTX) were recently introduced for metastatic pancreatic cancer treatment. However, studies that compared these two regimens and studies in Asian populations are lacking. AIM: To compare the treatment outcomes of FOLFIRINOX and Gem...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, In Rae, Kang, Huapyong, Jo, Jung Hyun, Lee, Hee Seung, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, An, Chansik, Park, Mi-Suk, Bang, Seungmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031147/
https://www.ncbi.nlm.nih.gov/pubmed/32104549
http://dx.doi.org/10.4251/wjgo.v12.i2.182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031147/
https://www.ncbi.nlm.nih.gov/pubmed/32104549
http://dx.doi.org/10.4251/wjgo.v12.i2.182

Ejemplares similares